UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Gogo Inc
GOGO
$389M
| $1.79M | ﹤0.01% |
208,566
-99,683
| -32% | -$1.26M |
|
1802
Fluence Energy
FLNC
$2.4B
| $1.79M | ﹤0.01% |
165,550
-102,932
| -38% | -$860K |
|
1803
Stoke Therapeutics
STOK
$2.1B
| $1.78M | ﹤0.01% |
75,858
-31,382
| -29% | -$538K |
|
1804
Edgewell Personal Care
EPC
$1.31B
| $1.77M | ﹤0.01% |
87,065
-63,492
| -42% | -$1.49M |
|
1805
AMN Healthcare
AMN
$1.26B
| $1.77M | ﹤0.01% |
91,222
-47,547
| -34% | -$929K |
|
1806
LGI Homes
LGIH
$1.35B
| $1.76M | ﹤0.01% |
33,976
-24,785
| -42% | -$1.45M |
|
1807
QuinStreet
QNST
$1.2B
| $1.76M | ﹤0.01% |
113,469
-68,671
| -38% | -$1.09M |
|
1808
NXP Semiconductors
NXPI
$59.1B
| $1.75M | ﹤0.01% |
7,698
-3,320,562
| -100% | -$747M |
|
1809
Amplitude
AMPL
$1.6B
| $1.74M | ﹤0.01% |
162,602
-58,216
| -26% | -$691K |
|
1810
Adtran
ADTN
$624M
| $1.74M | ﹤0.01% |
185,746
+6,594
| +4% | +$61.4K |
|
|
SEI
1811
Solaris Energy Infrastructure
SEI
$3.89B
| $1.74M | ﹤0.01% |
43,498
-39,589
| -48% | -$1.24M |
|
1812
10x Genomics
TXG
$7.63B
| $1.73M | ﹤0.01% |
148,387
-114,261
| -44% | -$1.49M |
|
1813
Pennant Group
PNTG
$1.33B
| $1.73M | ﹤0.01% |
68,658
-55,419
| -45% | -$1.36M |
|
|
CIM
1814
Chimera Investment
CIM
$997M
| $1.73M | ﹤0.01% |
130,762
-96,042
| -42% | -$1.34M |
|
1815
Immunovant
IMVT
$8.36B
| $1.73M | ﹤0.01% |
107,224
-93,036
| -46% | -$1.51M |
|
1816
Photronics
PLAB
$1.94B
| $1.72M | ﹤0.01% |
74,888
-64,786
| -46% | -$1.39M |
|
1817
Logitech
LOGI
$14.9B
| $1.7M | ﹤0.01% |
15,477
-4,147,340
| -100% | -$417M |
|
1818
Deluxe
DLX
$1.1B
| $1.69M | ﹤0.01% |
87,525
-56,651
| -39% | -$1.03M |
|
1819
Universal Corp
UVV
$1.15B
| $1.68M | ﹤0.01% |
30,062
-40,319
| -57% | -$2.23M |
|
1820
Mission Produce
AVO
$1.14B
| $1.68M | ﹤0.01% |
139,356
-101,686
| -42% | -$1.26M |
|
1821
Driven Brands
DRVN
$2.04B
| $1.67M | ﹤0.01% |
103,936
-97,645
| -48% | -$1.7M |
|
1822
Compass Minerals
CMP
$1.12B
| $1.67M | ﹤0.01% |
86,944
-57,592
| -40% | -$1.14M |
|
1823
Safety Insurance
SAFT
$1.52B
| $1.67M | ﹤0.01% |
23,601
-19,105
| -45% | -$1.39M |
|
1824
Cadre Holdings
CDRE
$1.44B
| $1.66M | ﹤0.01% |
45,560
-49,091
| -52% | -$1.58M |
|
1825
Preferred Bank
PFBC
$1.27B
| $1.66M | ﹤0.01% |
18,365
-17,676
| -49% | -$1.64M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.